Respiratory Care Devices Market Key Companies and SWOT Analysis by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPAR100001120
  • Category : Life Sciences
  • No. of Pages : 347
  • Available Report Formats : pdf-format excel-format
Buy Now
Respiratory Care Devices Market Key Companies and SWOT Analysis by 2028
Report Date: May 2022   |   Report Code: TIPAR100001120 Email: sales@theinsightpartners.com
Buy Now

The respiratory care devices market is expected to grow from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028; it is estimated to register a CAGR of 8.9% from 2021 to 2028.

Respiratory care devices are the medical instruments used for diagnosis, monitoring, and care of patients suffering from various respiratory diseases. Major devices such as oxygen concentrators, ventilators, inhalers, nebulizers, spirometers, and positive airway pressure (PAP) are primarily used to diagnose, treat, and monitor respiratory diseases. The introduction of innovative product launches, high adoption of cutting-edge technology, and integration of digital & sensor-based technologies for creating a smart portfolio will further aid the respiratory care devices market growth.

The report provides insights and in-depth analysis of the respiratory care devices market, emphasizing various parameters such as market trends, technological advancements, and market dynamics. It also provides the competitive landscape analysis of leading market players and the impact of the COVID-19 pandemic on the respiratory care devices market across all major regions. The COVID-19 pandemic affected three main aspects of the global economy – manufacturing, supply chain, and financial markets. However, the impact of the COVID-19 pandemic on the respiratory care devices market was positive. During the pandemic, the proportionate use of respiratory care devices came into the limelight and gained traction. The coordination between organizations and countries unfolded the overall potential of all regions. For instance, South Africa could not source a sufficient number of ventilators from global markets to meet local demand. In June 2020, the Minister of Trade, Industry, and Competition initiated the National Ventilator Project (NVP) to tackle the rising ventilator demand. Under the guidance of the Cabinet and the National Command Council, the NVP looked to engage local manufacturers to produce fit-for-purpose and noninvasive ventilators. This effort is overseen by the Department of Trade, Industry, and Competition (DTIC) and implemented by the South African Radio Astronomy Observatory (SARAO). As a result, astronomy capacity helped manufacture 20,000 ventilators by November 2020 at the cost of US$ 900 per device.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Published Report - Respiratory Care Devices Market: Strategic Insights

global-respiratory-care-devices-report
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Based on region, the respiratory care devices market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.

Lucrative Regions for Respiratory Care Devices Market

Lucrative Regions for Respiratory Care Devices Market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights
Growing R&D Investment in Respiratory Care Devices Drives Respiratory Care Devices Market

Medical device research and development are considered highly capital-intensive and fraught with enormous risks. R&D is an essential step, after which the best ideas are converted into the best products. A thriving R&D ecosystem can become the perfect nurturing ground for developing globally competitive and top-of-the-line products, from conceiving an ideal product design to new product development, prototyping, validation, and testing. To produce innovative products, MedTech companies are investing a huge part of revenue in R&D. For instance:

  • In 2021, ResMed invested US$ 225.3 million in research and development activities, representing 7.0% of their net revenues from 2021 and 12% from 2020. With a continued focus on developing and commercializing new, innovative products and solutions, the company aims to improve patient outcomes, help physicians and providers better manage chronic disease, and lower healthcare costs.
  • In May 2021, Sanichi Technology Bhd completed its research and development phase for medical-grade mechanical air ventilators, slated to be distributed to local and overseas healthcare markets.

Further, the medical device industry is poised for steady growth. The rising need for respiratory care devices reflects the increasing demand for innovative devices such as wearables and services (health data). Respiratory care device manufacturers are racing to meet the demand in ventilator production to potentially avoid the looming shortage and the possible need to ration respiratory devices. For instance, Zoll Medical announced producing 10,000 ventilators per month in response to the COVID-19 pandemic. This represents a 25-fold increase in its production volume, and it is prepared to expand its supply base as necessary. Other efforts include a collaboration between device maker Ventec Life Systems and GM to develop its ventilator production. ResMed announced its goal to double or triple ventilator output and scale-up ventilation mask production more than 10-fold.

Product-Based Insights

Based on product, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. In 2022, the therapeutic devices segment accounted for the largest market share. It is expected to be one of the fastest-growing segments. The market position of this segment has increased due to the major use of PAP devices, ventilators, and oxygen concentrators.

Respiratory Care Devices Market, by Product – 2022 and 2028

Respiratory Care Devices Market, by Product – 2022 and 2028

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Indication-Based Insights

Based on indication, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. The COPD segment held the largest market share, whereas the asthma segment is anticipated to be the fastest-growing segment during the forecast period. With the increasing prevalence of chronic obstructive pulmonary disease (COPD) caused by air pollution, passive smoking, and several other factors, both segments are expected to surge during the forecast period.

End User-Based Insights

Based on end user, the respiratory care devices market is segmented into hospitals, home care, and ambulatory care. The hospitals segment held the largest respiratory care devices market share, whereas the home care segment is expected to be the fastest-growing one.

The respiratory care devices market players are adopting organic strategies such as product launch and expansion to expand their footprint and product portfolio globally.

Company Profiles

  • Koninklijke Philips N.V.
  • ResMed Inc.
  • Medtronic
  • Masimo
  • THERMO FISHER SCIENTIFIC INC.
  • Dragerwerk AG & Co. KGaA
  • Invacare Corporation
  • Getinge AB.
  • Nihon Kohden Corporation
  • Air Liquide
  • Teleflex Incorporated

Published Report - Respiratory Care Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 18.11 Billion
Market Size by 2028 US$ 32.76 Billion
Global CAGR (2021 - 2028) 8.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables & Accessories
By Indication
  • Chronic Obstructive Pulmonary Diseases
  • Sleep Apnea
  • Asthma
  • Infectious Diseases
By End User
  • Hospitals
  • Home Care
  • Ambulatory Care
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Koninklijke Philips N.V.
  • ResMed Inc
  • Medtronic
  • Masimo
  • THERMO FISHER SCIENTIFIC INC.
  • Dragerwerk AG & Co. KGaA
  • Invacare Corporation
  • Getinge AB.
  • Nihon Kohden Corporation
  • Air Liquide
  • Teleflex Incorporated

Published Report - Respiratory Care Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Respiratory Care Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

global-respiratory-care-devices-report-cagr


Frequently Asked Questions

Respiratory care devices are those medical instruments which are used for the diagnosis, monitoring and care of patients who are suffering from various respiratory diseases. Major devices such as oxygen concentrator, ventilators, inhalers, nebulizers, spirometers, positive airway pressure (PAP) are primarily used for respiratory disease’s diagnostic, therapeutic, and monitoring.. Introduction of innovative product launches and high adoption of cutting edge technology and integration of digital and sensor based technologies for creating a smart, portfolio, and connected respiratory care devices will further aid the growth of the market..

Increasing prevalence of infectious respiratory diseases is one of the most significant factors responsible for the overall market growth.

Based on product, therapeutic devices took the forefront leaders in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

The chronic obstructive pulmonary diseases (COPD) segment dominated the global respiratory care diseases market and accounted for the largest revenue of US $7,232.37 million in 2021.

Koninklijke Philips N.V., ResMed Inc, Medtronic, Masimo, THERMO FISHER SCIENTIFIC INC., Dragerwerk AG & Co. KGaA, Invacare Corporation, Getinge AB., Nihon Kohden Corporation, Air Liquide, Teleflex Incorporated, are among the leading companies operating in the global respiratory care devices market

Global respiratory care devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for generic injectables market. The US is estimated to hold the largest share in the generic injectables market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for respiratory care devices accounting fastest growth of the region during the coming years.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Jun 2022